ANDREW BLACK: Open Payments
NPI 1346726999 · MEDINA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$156 in 9 payments from 7 companies in 2025. Trend: 2023 $95 · 2024 $151 · 2025 $156
Food & beverage: $156
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Corcept Therapeutics | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $14 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: AIRSUPRA, GVOKE HYPOPEN, Korlym, GEMTESA, REXULTI, FARXIGA, Auvelity, CAMZYOS.
Industry payments across OH — which companies pay providers there.
